Evidence map›Paper›PMID 26290896›Full record

ArticleInflammation and cell signaling2014

PPARδ and PGE

Dingzhi Wang, Raymond N DuBois

Open access · goldAbstract read
In one paragraph

Article in Inflammation and cell signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Matrine Alleviates Oxidative Stress and Inflammation in Colon Cancer by Activating the Nrf2 Pathway.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis.International journal of molecular sciences · 2020
    Review
  11. Article
  12. The Potential of the FSP1cre-International journal of molecular sciences · 2019
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dingzhi WangLaboratory for Inflammation and Cancer, the Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Raymond N DuBoisLaboratory for Inflammation and Cancer, the Biodesign Institute at Arizona State University, Tempe, AZ 85287 ; Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287 ; Department of Research and Division of Gastroenterology, Mayo Clinic, Scottsdale, AZ 85259.
Arizona State University · US

Funding

THE ROLE OF ENDOCANNABINOIDS AND THEIR RECEPTORS IN COLORECTAL CANCERP01CA077839 · NCI · VANDERBILT UNIVERSITY · PI DUBOIS, RAYMOND N. · 1999 to 2016
$17.8M
Role of Eicosanoids in Intestinal BiologyR01DK047297 · NIDDK · VANDERBILT UNIVERSITY · PI DUBOIS, RAYMOND N. · 1994 to 2018
$2.6M
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal CancerR01CA184820 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DUBOIS, RAYMOND N. · 2014 to 2017
$1.6M
NCI NIH HHS P01 CA077839NCI NIH HHS R01 CA184820NIDDK NIH HHS R01 DK047297
6 · The paper itself

Abstract

The nuclear hormone receptor peroxisome proliferator-activated receptor δ (PPARδ) is a ligand-dependent transcription factor that is involved in fatty acid metabolism, obesity, wound healing, inflammation, and cancer. Despite decades of research, the role of PPARδ in inflammation and colorectal cancer remains unclear and somewhat controversial. Our recent work presented the first genetic evidence demonstrating that PPARδ is required for chronic colonic inflammation and colitis-associated carcinogenesis. We also found that a PPARδ downstream pathway, namely the COX-2-derived PGE

Indexed as

and COX-2-drived PGE2chemokinescolitis-associated tumorigenesisColorectal cancerinflammationperoxisome proliferator-activated receptor

Identifiers

PMID26290896
PMCPMC4539244
OpenAlexW1595058855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.